CRYO-CELL INTERNATIONAL, INC. Contract with Customer, Liability, Noncurrent
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Contract with Customer, Liability, Noncurrent of $53.27 million as of 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2026-07-15
- 2026-05-31: Contract with Customer, Liability, Noncurrent $53.27M.
- 2026-02-28: Contract with Customer, Liability, Noncurrent $52.10M.
- 2025-11-30: Contract with Customer, Liability, Noncurrent $50.97M.
- 2025-08-31: Contract with Customer, Liability, Noncurrent $49.84M.
| Period end | Contract with Customer, Liability, Noncurrent | Contract with Customer, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-05-31 | $53.27M 10-Q · filed 2026-07-15 | |
| 2026-02-28 | $52.10M 10-Q · filed 2026-04-14 | |
| 2025-11-30 | $50.97M 10-Q · filed 2026-07-15 | |
| 2025-08-31 | $49.84M 10-Q · filed 2025-10-15 | |
| 2025-05-31 | $48.82M 10-Q · filed 2025-07-15 | |
| 2025-02-28 | $47.73M 10-Q · filed 2025-04-14 | |
| 2024-11-30 | $46.56M 10-K · filed 2026-02-27 | |
| 2024-08-31 | $45.20M 10-Q · filed 2024-10-15 | |
| 2024-05-31 | $43.92M 10-Q · filed 2024-07-15 | |
| 2024-02-29 | $42.60M 10-Q · filed 2024-04-15 | |
| 2023-11-30 | $41.19M 10-K · filed 2025-02-28 | |
| 2023-08-31 | $39.97M 10-Q · filed 2023-10-12 | |
| 2023-05-31 | $38.65M 10-Q · filed 2023-07-14 | |
| 2023-02-28 | $37.25M 10-Q · filed 2023-04-21 | |
| 2022-11-30 | $36.00M 10-K · filed 2024-02-28 | |
| 2022-08-31 | $34.67M 10-Q · filed 2022-10-18 | |
| 2022-05-31 | $33.37M 10-Q · filed 2022-07-11 | |
| 2022-02-28 | $32.15M 10-Q · filed 2022-04-13 | |
| 2021-11-30 | $31.27M 10-K · filed 2023-02-28 | |
| 2021-08-31 | $30.40M 10-Q · filed 2021-10-15 | |
| 2021-05-31 | $29.13M 10-Q · filed 2021-07-15 | |
| 2021-02-28 | $27.95M 10-Q · filed 2021-04-14 | |
| 2020-11-30 | $27.20M 10-K · filed 2022-02-22 | |
| 2020-08-31 | $26.20M 10-Q · filed 2020-10-15 | |
| 2020-05-31 | $25.31M 10-Q · filed 2020-07-10 | |
| 2020-02-29 | $24.45M 10-Q · filed 2020-04-14 | |
| 2019-11-30 | $23.63M 10-K · filed 2021-03-01 | |
| 2019-08-31 | $22.89M 10-Q · filed 2019-10-15 | |
| 2019-05-31 | $20.32M 10-K · filed 2021-03-01 | $21.98M 10-Q · filed 2019-07-15 |
| 2019-02-28 | $21.12M 10-Q · filed 2019-04-15 | |
| 2018-11-30 | $20.32M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |